McKesson Corporation
MCKNYSETrackedMarket Data VerifiedHealth CareHealth Care Distributors
- Coverage
- Coverage universe Identity published; no third-party ESG observation yet.
- ESG profile reviewed
- Last editorial update to this profile.
- Quote
- Last verified closeObservation time is shown beside the price.
- Methodology
- How we rateProvider ratings are shown separately, never blended.
Market overview
Up+USD 2.56 (+0.29%) Day change
The market is closed. This is the last verified closing quote, not an intraday price.
- Open
- USD 889.25
- Previous close
- USD 889.12
- Day high
- USD 897.46
- Day low
- USD 881.12
- Volume
- 935,711
- Market cap
- USD 103,961,288,704
View Chart Data
| Date and time | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| USD 696.90 | USD 707.18 | USD 692.86 | USD 705.55 | 679,800 | |
| USD 690.98 | USD 697.98 | USD 688.00 | USD 690.13 | 518,700 | |
| USD 754.91 | USD 759.32 | USD 747.60 | USD 757.96 | 423,200 | |
| USD 794.40 | USD 807.75 | USD 791.63 | USD 801.67 | 476,400 | |
| USD 842.91 | USD 861.98 | USD 842.04 | USD 859.37 | 571,700 | |
| USD 875.00 | USD 891.60 | USD 873.64 | USD 889.28 | 829,200 | |
| USD 798.15 | USD 815.91 | USD 793.92 | USD 813.10 | 1,192,600 | |
| USD 826.82 | USD 830.00 | USD 823.34 | USD 828.26 | 179,900 | |
| USD 826.41 | USD 836.60 | USD 820.03 | USD 823.98 | 487,000 | |
| USD 830.00 | USD 849.05 | USD 820.85 | USD 822.30 | 677,700 | |
| USD 917.41 | USD 938.03 | USD 915.08 | USD 934.75 | 874,000 | |
| USD 989.05 | USD 999.00 | USD 973.00 | USD 995.69 | 571,700 | |
| USD 938.94 | USD 944.42 | USD 916.61 | USD 920.35 | 767,400 | |
| USD 872.17 | USD 887.25 | USD 866.79 | USD 884.28 | 570,800 | |
| USD 864.99 | USD 873.03 | USD 853.43 | USD 859.04 | 582,200 | |
| USD 809.51 | USD 811.96 | USD 800.30 | USD 801.01 | 882,200 | |
| USD 761.23 | USD 765.51 | USD 751.48 | USD 754.68 | 1,088,700 | |
| USD 764.00 | USD 781.27 | USD 759.85 | USD 775.66 | 982,000 | |
| USD 751.70 | USD 757.18 | USD 744.45 | USD 744.85 | 1,454,600 | |
| USD 807.85 | USD 823.86 | USD 803.39 | USD 818.66 | 1,125,400 | |
| USD 811.46 | USD 825.02 | USD 809.94 | USD 824.49 | 755,400 | |
| USD 864.34 | USD 889.69 | USD 864.32 | USD 869.58 | 1,562,200 | |
| USD 861.47 | USD 875.64 | USD 859.75 | USD 873.79 | 600,500 | |
| USD 889.25 | USD 895.27 | USD 881.11 | USD 894.15 | 216,071 |
Company Profile & Business Model Overview
McKesson Corporation provides healthcare supply chain management, retail pharmacy, community oncology and specialty care, and healthcare information solutions in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The International segment offers distribution and services to wholesale, institutional, and retail customers in 13 European countries and Canada. The Medical-Surgical Solutions segment provides medical-surgical supply distribution, logistics, and other services to healthcare providers. The RxTS segment offers CoverMyMeds solution to help patients get the medications; RelayHealth, a workflow solution; RxCrossroads solution for therapies and interventions to biopharma manufacturers; and McKesson Prescription Automation, a customized pharmacy automation technology; and Multi-Client Central Fill as a Service, a pharmacy. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
Sustainability Strengths & Catalysts (Pros)
- Sustainalytics "Strong" ESG management rating with comprehensive impact reporting
- Critical healthcare infrastructure delivering 1/3 of North American medications
- 18% revenue growth with expanding margins in specialty pharmaceuticals
Material Risks & Governance Concerns (Cons)
- Pharmaceutical distribution role in opioid crisis creates reputational risks
- Drug pricing transparency pressures impact social responsibility scores
Related ESG Peer Equities
Companies in Health Care evaluated across carbon intensity, social metrics, and board governance.
ESG & Sustainability Rating Breakdown
Synthesized multi-provider rating across Environmental, Social, and Corporate Governance dimensions.
Audited Methodology
Formal published scorecards from MSCI ESG Research and Sustainalytics are not currently available for this ticker. The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.
Data integrity and methodology
MSCI and Sustainalytics ratings are shown separately with their own observation dates; they are not blended into one score, and providers can disagree. Market quotes are delayed or last-close values, and every snapshot states its source and observation time. Read the full rating methodology.
Financial & Valuation Fundamentals
Core balance sheet and equity valuation metrics sourced from corporate filings.
Audited Financials
Related ESG Financial Tools & Modeling
ESG Investment Growth Calculator
Project compound future portfolio values versus traditional index benchmarks.
Launch Tool →
Portfolio Carbon Footprint Calculator
Translate your investment capital into financed greenhouse gas emissions.
Launch Tool →
Green Mortgage Calculator
Calculate interest rate discounts on energy-efficient certified homes.
Launch Tool →
Featured Sustainable Investment Research & Guides
Top 12 Impact Investing Apps & Platforms (Reviewed)
Comprehensive review of the best ESG micro-investing and direct indexing apps.
Biblically Responsible Investing (BRI): Top Stocks & Funds
Faith-based screening criteria, ESG alignment, and values-based portfolio strategies.
Top Desalination & Clean Water Infrastructure Stocks
Invest in global clean water purification, reverse osmosis, and municipal utilities.
Best Certified B-Corp Banks & Sustainable Banking
How to align your everyday cash reserves with social and climate impact standards.
Frequently Asked Questions
Direct answers on sustainability scores, risk methodologies, and peer rankings.
What is McKesson Corporation (MCK)'s ESG rating and sustainability score?
Formal published scorecards from MSCI and Sustainalytics are under ongoing review for McKesson Corporation (MCK). The Impact Investor tracks corporate sustainability disclosures, SEC 10-K filings, and governance releases.
Is McKesson Corporation considered an ESG leader or laggard in Health Care?
Independent benchmark status for McKesson Corporation is evaluated relative to Health Care peers once third-party coverage publishes official methodology scores.
What are the main ESG risks and controversies for McKesson Corporation?
Key material risks for McKesson Corporation include: Pharmaceutical distribution role in opioid crisis creates reputational risks; Drug pricing transparency pressures impact social responsibility scores. Investors should evaluate whether corporate mitigation plans adequately address these vulnerabilities.
How does The Impact Investor evaluate ESG stock profiles?
The Impact Investor presents audited third-party ratings from MSCI and Sustainalytics alongside delayed market data and financial fundamentals. We do not blend ratings into proprietary black-box scores, and ratings are never modified by advertising or affiliate relationships.